Endovia Health Sciences, Inc. (EDVA) Net margin 2016–2025
Endovia Health Sciences, Inc. (EDVA) net profit margin by fiscal year — reported net income divided by reported revenue.
-34537.0%FY2025 · since FY2016: -4.8% → -34537.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -34537.0% | -31572.2 pp |
| FY2024 | -2964.9% | -2853.4 pp |
| FY2023 | -111.4% | +8.5 pp |
| FY2022 | -119.9% | +136.8 pp |
| FY2021 | -256.7% | +989.9 pp |
| FY2020 | -1246.7% | +23944.6 pp |
| FY2019 | -25191.2% | -25196.4 pp |
| FY2018 | 5.2% | +21.7 pp |
| FY2017 | -16.5% | -11.7 pp |
| FY2016 | -4.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More EDVA financial trends
EDVA RevenueEDVA Net incomeEDVA Gross profitEDVA Gross marginEDVA Operating incomeEDVA Operating marginEDVA Operating cash flowEDVA Free cash flowEDVA Capital expendituresEDVA Return on equityEDVA Stock buybacksEDVA Dividends paidEDVA Total assetsEDVA Total liabilitiesEDVA Shareholders’ equityEDVA overview →